Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.73 USD | +3.41% | +0.74% | +72.78% |
Business Summary
Number of employees: 37
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Bispecific Antibodies
100.0
%
| 20 | 100.0 % | 7 | 100.0 % | -64.09% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Netherlands
100.0
%
| 20 | 100.0 % | 7 | 100.0 % | -64.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 01/19/01 | |
Fred M. Powell
DFI | Director of Finance/CFO | 63 | 01/22/01 |
Chief Tech/Sci/R&D Officer | - | 09/21/09 | |
Chief Tech/Sci/R&D Officer | 50 | 01/17/01 | |
Chief Tech/Sci/R&D Officer | 59 | 06/23/06 | |
Chief Tech/Sci/R&D Officer | 60 | 01/18/01 | |
Robin Hume
LAW | General Counsel | - | 15/23/15 |
Human Resources Officer | - | 09/21/09 | |
Amy Garabedian
LAW | General Counsel | - | 27/21/27 |
Peter Ros
PRN | Corporate Officer/Principal | 52 | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 01/19/01 | |
Karen Wilson
BRD | Director/Board Member | 61 | 01/21/01 |
James Noble
BRD | Director/Board Member | 65 | 15/22/15 |
Peter Kiener
BRD | Director/Board Member | 72 | 01/23/01 |
Jay Backstrom
BRD | Director/Board Member | 69 | 15/22/15 |
Kapil Dhingra
CHM | Chairman | 64 | 22/21/22 |
Mary Wadlinger
BRD | Director/Board Member | 64 | 01/23/01 |
Christy Oliger
BRD | Director/Board Member | 54 | 09/23/09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 26,289,087 | 18,738,315 ( 71.28 %) | 0 | 71.28 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.78% | 71.77M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- LVTX Stock
- Company LAVA Therapeutics N.V.